Table 4.
Variables | Germany | Netherlands | United Kingdom | |||||
---|---|---|---|---|---|---|---|---|
Unit cost (€) | Resource units or probability of use | Unit cost (€) | Resource units or probability of use | Unit cost (€) | Resource units or probability of use | |||
Direct costs: | ||||||||
Vaccine and administration costs | 16*† | 2 doses | 16*† | 2 doses | 16*† | 2 doses | ||
Visits to doctor if influenza-like illness | 9.7041 | 24%13 | 21.8024 | 24%13 | 44.40‡ | 24%13 | ||
Antibiotics prescribed by doctor | 20.5041 | 17.5%41 | 6.90142 | 20%42 | 9.6043 | 20%42 | ||
Oseltamivir (Tamiflu) prescribed by doctor* | 2144 | Treatment course | 2144 | Treatment course | 2144 | Treatment course | ||
Over-the-counter drugs for influenza-like illness | 642 | 80%41 | 6.3042 | 80%42 | 7.3043 | 80%42 | ||
Episode of hospital stay | 407541 | — | 339824 | — | 2892‡ | — | ||
Production losses: | ||||||||
Per day, ages 20-40 | 23341 | — | 21342 | — | 118‡ | — | ||
Per day, ages 40-65 | 23341 | — | 25542 | — | 132‡ | — | ||
Days of absence, all ages | — | 2.1641 | — | 3.2542 | — | 2.9‡ |
Dutch data are used when country specific data are missing. Prices updated to 2008 using country specific consumer price index.
*Per dose, including costs of administering drug.
†Assumed the same for all three countries.
‡Personal communication, K Tolley, 2008.